Author

C. Brander

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 4 Organism:human· 4 Approach:experimental assay· 3 Assay:bulk RNA-seq· 1 Assay:flow cytometry· 1 Assay:metagenomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Clotet· 3 shared B. Mothe· 2 shared D. Ouchi· 2 shared E. Jimenez-Moyano· 2 shared J. G Prado· 2 shared M. Ruiz-Riol· 2 shared O. Blanch-Lombarte· 2 shared R. Paredes· 2 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. Clotet

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

PD-1 blockade enhances HIV-1 vaccine-induced CD8+ T-cell responses in PWH early ART-treated

M. Marin, A. Ruiz, E. Jimenez-Moyano, D. Ouchi, O. Blanch-Lombarte, R. Penya, D. Gorman, R. Barnard, T. Hanke, B. Clotet, B. J. Howell, C. Brander, B. Mothe, J. G Prado

This study shows PD-1 blockade enhances HIV-1 vaccine-induced CD8+ T-cell responses in early ART-treated PWH, improving proliferation, IFN-gamma production, and activation.

bioRxiv · Jul 5, 2024 · PreprintImmunology

Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells

M. Kobayashi-Ishihara, K. F. Smutna, F. E. Alonso, J. Argilaguet, A. Esteve-Codina, K. Geiger, M. Genesca, J. Grau-Exposito, C. Duran-Castells, S. Rogenmoser, R. Böttcher, J. Jungfleisch, B. Oliva, J. P. Martinez, M. Li, , A. Meyerhans

This study identifies SLFN12 as an HIV-1 restriction factor that inhibits viral replication and reactivation through codon-usage dependent post-transcriptional block in CD4+ T cells.

bioRxiv · Nov 9, 2022Immunology

Gut Microbiome Signatures Linked to HIV-1 Reservoir Size and Viremia Control

A. Borgognone, M. Noguera-Julian, B. Oriol, L. Noël-Romas, M. Ruiz-Riol, Y. Guillen, M. Parera, M. Casadella, C. Duran, M. C. Puertas, F. Catala-Moll, M. De Leon, S. Knodel, K. Birse, C. Manzardo, , R. Paredes

The paper identifies gut microbiome signatures, specifically the Bacteroidales/Clostridiales ratio, associated with HIV-1 reservoir size and viremia control in a clinical trial.

bioRxiv · Oct 3, 2021Immunology

Highly functional Cellular Immunity in SARS-CoV-2 Non-Seroconvertors is associated with immune protection

A. Kilpelainen, E. Jimenez-Moyano, O. Blanch-Lombarte, D. Ouchi, R. Penya, B. Quirant-Sanchez, A. Chamorro, I. Blanco, E. Martinez-Caceres, R. Paredes, L. Mateu, J. Carrillo, J. Blanco, C. Brander, M. Massanella, , J. G Prado

The paper examines T-cell immunity in SARS-CoV-2 non-seroconvertors, finding high functional T-cell responses and low immune activation correlate with protection from severe disease without seroconversion.

bioRxiv · May 4, 2021 · PreprintImmunology